SCHEMBL13152564

SCHEMBL13152564

CCCn1cc(N)c2cc(Br)ccc21

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 1/20 0.43
▸ CYP19A1 P11511 2/20 0.42
▸ CNR2 P34972 6/20 0.42
▸ LMNA P02545 1/20 0.39
▸ CNR1 P21554 5/20 0.39
▸ HTR6 P50406 1/20 0.37
▸ ABCC2 Q92887 1/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ DNM1 Q05193 2/20 0.36
▸ IDO1 P14902 1/20 0.36
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13152593 0.87 LMNA (0.50) DYRK1ACYP19A1LMNAHTR6ABCC2
SCHEMBL15792328 0.81 ICMT (0.49) CYP19A1CNR2CNR1HTR6ALDH1A1
SCHEMBL31504554 0.78 PDK1 (0.45) DYRK1ACYP19A1ABCC2SMN1; SMN2DNM1
SCHEMBL10095336 0.77 SMN1; SMN2 (0.57) CYP19A1SMN1; SMN2MAPT
SCHEMBL13806313 0.76 CNR2 (0.50) CNR2CNR1ALDH1A1
SCHEMBL24144136 0.76 CYP19A1 (0.44) CYP19A1CNR2LMNACNR1HTR6
SCHEMBL13152683 0.73 LMNA (0.41) DYRK1ACYP19A1CNR2LMNACNR1
Iodide SCHEMBL27771052 0.72 CNR2 (0.48) CNR2LMNACNR1ABCC2SMN1; SMN2
SCHEMBL14136899 0.72 IDO1 (0.67) CNR2LMNACNR1IDO1
SCHEMBL29556827 0.72 MAPT (0.51) LMNASMN1; SMN2ALDH1A1DNM1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010118009-A1 HCV INHIBITOR AND THERAPEUTIC AGENT COMBINATIONS PTC THERAPEUTICS, INC. (US) 2010-10-14 — — WO disclosed
Send feedback